Insider filing · AXSM
Mark L. Jacobson
Chief Operating Officer
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Mark L. Jacobson sold $4.2M of Axsome Therapeutics (AXSM)
Executed May 27 2025, disclosed May 28 2025, 1 day later.
Value, as filed
$4.2M
40,673 sh across 2 lots
Executed
May 27 2025
the trade date, as filed
Disclosed
May 28 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MJMark L. Jacobson (Chief Operating Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $5.7M of AXSM (35,378 sh × $161.88, as filed), executed Feb 26.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark L. Jacobson in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$2.1M10,000 sh × $208.65
Exec Sep 3
Filed Sep 3 · 7:09 PM ET AXSMSALE Axsome Therapeutics, Inc. $1.0M
4,517 sh × $227.94
Exec May 4
Filed May 5 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $5.7M
35,378 sh × $161.88
Exec Feb 26
Filed Feb 27 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $1.2M
10,000 sh × $115.96
Exec Sep 22 2025
Filed Sep 22 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $5.2M
45,783 sh across 2 lots
Exec Sep 16 2025
Filed Sep 17 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $2.8M
25,000 sh × $110.44
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET